SCHEMBL6668211

SCHEMBL6668211

COc1c(NC(=O)Nc2ccc(-c3cnc4c(c3)NC(=O)C(Cc3ccccc3)O4)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.58
EGFR P00533 1/20 0.58
RAF1 P04049 1/20 0.58
LYN P07948 1/20 0.58
BRAF P15056 1/20 0.58
EPHA2 P29317 1/20 0.58
EPHA3 P29320 1/20 0.58
AKT1 P31749 1/20 0.58
MAPK9 P45984 1/20 0.58
MAPK14 Q16539 9/20 0.51
GSK3A P49840 12/20 0.47
SRC P12931 10/20 0.46
SYK P43405 10/20 0.46
LCK P06239 1/20 0.46
CXCL8 P10145 4/20 0.45
CYP3A4 P08684 1/20 0.44
TNF P01375 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6667236 0.89 ABL1 (0.60) ABL1EGFRRAF1LYNBRAF
SCHEMBL6669726 0.87 MAPK14 (0.54) ABL1EGFRRAF1LYNBRAF
SCHEMBL6664158 0.83 ABL1 (0.63) ABL1EGFRRAF1LYNBRAF
SCHEMBL6669467 0.83 MAPK14 (0.53) ABL1EGFRRAF1LYNBRAF
SCHEMBL6883066 0.78 MAPK14 (0.54) ABL1EGFRRAF1LYNBRAF
SCHEMBL6668838 0.76 MAPK14 (0.53) ABL1EGFRRAF1LYNBRAF
SCHEMBL6669800 0.75 MAPK14 (0.56) ABL1EGFRRAF1LYNBRAF
SCHEMBL4092237 0.73 ABL1 (1.00) ABL1EGFRRAF1LYNBRAF
SCHEMBL13527348 0.73 ABL1 (0.86) ABL1EGFRRAF1LYNBRAF
SCHEMBL6546510 0.72 MAPK14 (0.73) ABL1EGFRRAF1LYNBRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1438048-A1 1,4-DISUBSTITUTED BENZO-FUSED UREA COMPOUNDS AS CYTOKINE INHIBITORS BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2004-07-21 EP claimed
WO-2003032989-A1 1,4-DISUBSTITUTED BENZO-FUSED UREA COMPOUNDS AS CYTOKINE INHIBITORS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2003-04-24 WO claimed
US-6825184-B2 FOR USE AS ANTI-INFLAMMATORY AGENTS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2004-11-30 US disclosed